Dec 12 (Reuters) - The European Medicines Agency has recommended the approval of GSK's (GSK.L), opens new tab add-on drug to treat asthma and a chronic inflammatory sinus condition, the company said ...
An expert panel of the EU drug regulator, the European Medicines Agency (EMA), endorsed seven new medicines for approval this week, including a cancer drug from ImmunityBio (IBRX) and Moderna's (MRNA) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results